The global prevalence of COPD is somewhere between 4 and 12%, and the prevalence and burden in the Middle East varies among countries and populations. Globally, there appears to be a shift in the prevalence of COPD towards younger individuals, women, and those exposed to respiratory risk factors beyond cigarette smoking. In this video, Dr. Jill Ohar and Dr. Bassam Mahboub describe the burden of COPD both in the Middle East and globally, and discuss practice considerations for the management of COPD in the context of the updated 2022 GOLD guideline recommendations.
Don’t miss the videos that are part of the same series:
- Initiating Nebulized Therapy in the Management of COPD
- Counselling and Education for the Use of Nebulized Therapy in the Management of COPD
In collaboration with COPD Foundation.
This program has received an unrestricted educational grant or in-kind support from Viatris.